 | | Vol. 10.07 – 4 March, 2024 |
| |
|
|
| Scientists developed an innovative in vitro human three-dimensional (3D) normal skin model and a multicellular model of human cutaneous squamous cell carcinoma using 3D bioprinting technology.
[Biofabrication] |
|
|
|
 | | PUBLICATIONSRanked by the impact factor of the journal |
| | DERMAL STEM CELLS & TISSUE REGENERATION |
|
|
|
| Investigators generated OCT4 knockout clonal cell lines using immortalized human skin keratinocytes to identify a functional role for the protein.
[Cell Reports] |
|
|
|
| Through analysis of GEO datasets, scientists found elevated Gasdermin E (GSDME) levels in psoriatic lesional skin. Additionally, GSDME levels correlated with both psoriasis severity and response to biologics treatments.
[Cell Death & Disease] |
|
|
|
| Treatment with cinnamic acid led to upregulation of oxytocin receptor and trichogenic gene expression in human dermal papilla cells.
[Scientific Reports] |
| |
|
|
| Autophagy-dependent melanoma cells were compared with normal foreskin fibroblasts to elucidate the mechanism by which 1-phosphatidylinositol 3-phosphate 5-kinase (PIKFYVE) inhibition induced cell death.
[Molecular Oncology] |
|
|
|
| Researchers established a daturataturin A (DTA) psoriasis-like keratinocytes model by stimulating HaCaT cells with M5 cocktail cytokines including interleukin (IL)-17A, IL-22, oncostatin M, IL-1α, and tumor necrosis factor-α, followed by intervention with DTA.
[Biochemical Genetics] |
|
|
|
|
| The authors focus on the mechanisms regulating the initiation of cutaneous melanoma dormancy as well as those that are involved in the reawakening of dormant cutaneous melanoma cells.
[Cancer Cell International] |
|
|
|
|
| A first-of-its-kind cellular immunotherapy pioneered at Moffitt Cancer Center is now available for patients with advanced melanoma. It’s called TIL, short for tumor-infiltrating lymphocyte therapy. The one-time T-cell therapy infusion uses a patient’s own immune cells to fight their cancer.
[Moffitt Cancer Center] |
|
|
|
|
| April 15 – 16, 2024
London, England, United Kingdom |
|
|
|
|
|
| | University of Texas Southwestern Medical Center – Dallas, Texas, United States |
|
|
|
| | Cyprus Cancer Research Institute – Aglandjia, Cyprus |
|
|
|
| | UC Davis – Davis, California, United States |
|
|
|
| | University of Michigan – Ann Arbor, Michigan, United States |
|
|
|
| | Augusta University – Augusta, Georgia, United States |
|
|
|
|
Cancer Stem Cell News
Cell Therapy News
Dermal Cell News
Endothelial Cell News
ESC & iPSC News
Extracellular Matrix News
Hematopoiesis News
Hepatic Cell News
Human Immunology News
Immune Regulation News
Intestinal Cell News
Mammary Cell News
Mesenchymal Cell News
Muscle Cell News
Neural Cell News
Organoid News
Pancreatic Cell News
Prostate Cell News
Pulmonary Cell News
